Septo-Optic Dysplasia
|
0.420 |
GermlineCausalMutation
|
disease |
ORPHANET |
More recently, we have implicated duplications of SOX3 and mutations of both SOX2 and SOX3 in the aetiology of variants of SOD.
|
17587179 |
2007 |
Septo-Optic Dysplasia
|
0.420 |
Biomarker
|
disease |
HPO |
|
|
|
XX males
|
0.330 |
AlteredExpression
|
disease |
BEFREE |
This is the first demonstration of altered SOX3 expression in an individual with XX male sex reversal and suggests that SOX3 can substitute for SRY to initiate male development in humans.
|
25781358 |
2015 |
XX males
|
0.330 |
Biomarker
|
disease |
BEFREE |
These data provide additional evidence that SOX3 gain-of-function in the XX bipotential gonad causes XX male sex reversal and further support the hypothesis that SOX3 is the evolutionary antecedent of SRY.
|
22678921 |
2012 |
XX males
|
0.330 |
GermlineCausalMutation
|
disease |
ORPHANET |
These data provide additional evidence that SOX3 gain-of-function in the XX bipotential gonad causes XX male sex reversal and further support the hypothesis that SOX3 is the evolutionary antecedent of SRY.
|
22678921 |
2012 |
XX males
|
0.330 |
GermlineCausalMutation
|
disease |
ORPHANET |
Importantly, we also identified genomic rearrangements within the SOX3 regulatory region in three patients with XX male sex reversal.
|
21183788 |
2011 |
XX males
|
0.330 |
GeneticVariation
|
disease |
BEFREE |
Importantly, we also identified genomic rearrangements within the SOX3 regulatory region in three patients with XX male sex reversal.
|
21183788 |
2011 |
46, XX Testicular Disorders of Sex Development
|
0.310 |
AlteredExpression
|
disease |
BEFREE |
We previously reported 5 cases of SRY-negative 46,XX testicular disorders of sex development and demonstrated that coordinated expression of genes such as SOX9, SOX3, and DAX1 was associated with testicular development.
|
24149105 |
2013 |
46, XX Testicular Disorders of Sex Development
|
0.310 |
GermlineCausalMutation
|
disease |
ORPHANET |
XX male sex reversal with genital abnormalities associated with a de novo SOX3 gene duplication.
|
22678921 |
2012 |
46, XX Testicular Disorders of Sex Development
|
0.310 |
GermlineCausalMutation
|
disease |
ORPHANET |
Identification of SOX3 as an XX male sex reversal gene in mice and humans.
|
21183788 |
2011 |
Kallmann Syndrome
|
0.300 |
GermlineCausalMutation
|
disease |
ORPHANET |
New insights into septo-optic dysplasia.
|
24802313 |
2014 |
Mental Retardation, X-Linked, with Isolated Growth Hormone Deficiency
|
0.300 |
GermlineCausalMutation
|
disease |
ORPHANET |
Phenotype-genotype correlations in congenital isolated growth hormone deficiency (IGHD).
|
22139958 |
2012 |
Kallmann Syndrome
|
0.300 |
GermlineCausalMutation
|
disease |
ORPHANET |
Septo-optic dysplasia and other midline defects: the role of transcription factors: HESX1 and beyond.
|
21396578 |
2011 |
HYPERTRICHOSIS, CONGENITAL GENERALIZED
|
0.300 |
GermlineCausalMutation
|
disease |
ORPHANET |
X-linked congenital hypertrichosis syndrome is associated with interchromosomal insertions mediated by a human-specific palindrome near SOX3.
|
21636067 |
2011 |
Kallmann Syndrome
|
0.300 |
GermlineCausalMutation
|
disease |
ORPHANET |
Genetics of septo-optic dysplasia.
|
17587179 |
2007 |
Mental Retardation, X-Linked, with Isolated Growth Hormone Deficiency
|
0.300 |
GermlineCausalMutation
|
disease |
ORPHANET |
Transcription factor SOX3 is involved in X-linked mental retardation with growth hormone deficiency.
|
12428212 |
2002 |
46,XX SEX REVERSAL 3
|
0.300 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Familial X-linked mental retardation and isolated growth hormone deficiency: clinical and molecular findings.
|
8826446 |
1996 |
Intellectual Disability
|
0.200 |
Biomarker
|
group |
BEFREE |
Xq27.1 duplication encompassing SOX3 has been implicated in the aetiology of X-linked hypopituitarism associated with intellectual disability and neural tube defects.
|
31678974 |
2019 |
Intellectual Disability
|
0.200 |
GeneticVariation
|
group |
BEFREE |
All of the patients studied who had both HB and ID had deletion of the SOX3 gene.
|
27477789 |
2016 |
Intellectual Disability
|
0.200 |
Biomarker
|
group |
BEFREE |
SOX3 involvement should be considered in a male with short stature due to GH deficiency associated with intellectual disability.
|
25402377 |
2015 |
Intellectual Disability
|
0.200 |
GeneticVariation
|
group |
BEFREE |
Both duplications encompassing SOX3 and loss-of function mutations in SOX3 have been reported in a minor portion of X-linked isolated growth hormone deficiency (GHD) or combined pituitary hormone deficiency (CPHD) patients with or without mental retardation.
|
24346842 |
2014 |
Intellectual Disability
|
0.200 |
Biomarker
|
group |
BEFREE |
In humans, over- and underdosage of SOX3 is associated with X-linked hypopituitarism with variable phenotypes ranging from isolated GH deficiency (GHD) to panhypopituitarism, with or without mental retardation and, in most cases, with reported pituitary imaging, an ectopic/undescended posterior pituitary.
|
25140394 |
2014 |
Intellectual Disability
|
0.200 |
GeneticVariation
|
group |
BEFREE |
In humans, duplication of SOX3 and polyalanine expansions at its C-terminus may cause intellectual disability and hypopituitarism.
|
23463539 |
2013 |
Intellectual Disability
|
0.200 |
GeneticVariation
|
group |
BEFREE |
Both overdosage of SOX3, as a result of gene duplication, and loss of function resulting from expansion of the first polyalanine (PA) tract are associated with variable degrees of hypopituitarism, with or without mental retardation.
|
21289259 |
2011 |
Intellectual Disability
|
0.200 |
GeneticVariation
|
group |
BEFREE |
A new 6-bp SOX-3 polyalanine tract deletion does not segregate with mental retardation.
|
17627381 |
2007 |